HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Dr Kade Enters OTC Dermatology Space With Sirius Acquisition

Executive Summary

German firm Dr Kade moves into the OTC dermatology category with an all-share acquisition of Sirius.

You may also be interested in...



Avoiding ‘Kiss Killers’ – GSK Offers German Consumers New Oral Hygiene Products For The Festival Season

With Carnival season approaching in Germany, GlaxoSmithKline is helping German consumers to take care of their oral hygiene with new toothbrushes and its Zovirax Duo cold sore treatment. 

Health Marketing Round-Up: January 2019

New OTC products and marketing campaigns in Germany, Australia and the UK.

Germany Begins The Year With Two Possible Rx-To-OTC Switches

Germany's Expert Committee for Prescription will meet on 22 January to consider two prescription-to-OTC switch applications: preparations containing a combination of ibuprofen and phenylephrine hydrochloride and hydrocortisone 1% for external use. 

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

RS148462

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel